Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Callan Jmb (CJMB) Liabilities and Shareholders Equity (2023 - 2025)

Callan Jmb (CJMB) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $7.7 million as the latest value for Q3 2025.

  • Quarterly Liabilities and Shareholders Equity rose 21.23% to $7.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $30.2 million through Sep 2025, up 2.45% year-over-year, with the annual reading at $5.1 million for FY2024, 47.63% down from the prior year.
  • Liabilities and Shareholders Equity hit $7.7 million in Q3 2025 for Callan Jmb, down from $9.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $9.7 million in Q4 2023 to a low of $5.1 million in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $7.5 million across 3 years, with a median of $7.4 million in 2024.
  • Biggest five-year swings in Liabilities and Shareholders Equity: crashed 47.63% in 2024 and later surged 32.84% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $9.7 million in 2023, then plummeted by 47.63% to $5.1 million in 2024, then soared by 52.21% to $7.7 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for CJMB at $7.7 million in Q3 2025, $9.0 million in Q2 2025, and $8.5 million in Q1 2025.